Content Library


Combination Products Forum 2019 Draft Agenda

The 3rd Annual Combination Products Forum 2019 will focus on the entire product life-cycle management process: From planning, design and implementation, right the way through to post-market maintenance and surveillance strategies.Through a range of interactive workshops, panel discussions, round-tables and case study presentations, key topics will focus on device development,...

Featured Content

Embracing Digital Platforms for Combination Products

Although still in the early stages of their development, digital healthcare platforms have the potential to improve patient outcomes, reduce healthcare costs, and allow communication and collaboration between doctors on a global scale. Pharma IQ spoke exclusively with Helene Gustafsson, Head of Regulatory & Clinical Compliance, LEO Pharma to discuss...

5 Key Considerations For Combination Product Regulations

The market for combination products is rapidly expanding, these products are advancing medical care and will likely have a significant impact on the industry in the coming years. Pharma IQ sat down with Audrey Clarembeaux, Head of Medical Device Development QA at UCB to discuss the key considerations that need...

Optimising Combination Product Development Using the E-Health Wave

Steve Dew, Associate Director Medical Devices and Combination Products, Biogen offered his insights into Optimising Combination Product Development Using the E-Health Wave, providing delegates with some thoughts about how digital health will transform the way we view combination products in patient care. 

Exclusive Content

Overcoming Combination Products Regulatory Challenges

Until now, combination products are more often handled inconsistently in different jurisdictions as drugs and/or devices. The determination as to which regulations, submission procedure and pathway to market is followed for the product is largely based on the its Primary Mode of Action, a new concept in itself. Ahead of...

The Drug-Device Combination Products Market Report

The global drug device combination product market is expected to reach USD 177.7 billion by 2024. With input from Medical Device Manufacturers, Pharmaceuticals, Consultants and Solution Providers, this report will explore the key drivers and challenges faced in the drug-device combination products market. 

Expert Insights: Lifecycle Management for Combination Products

Ensuring that combination products are effectively managed throughout their development, implementation, launch and post-launch is critical to long term success in the market. However, there is arguably still considerable room for improvement throughout this process, and in order to facilitate efficiency all parties must be fully aligned throughout the product...